drugset / Trial / NCT05577455

Efficacy of Traditional Chinese Medicine on Ameliorating IVF-ET Outcomes of Diminished Ovarian Reserve Patients

NCT05577455 ↗

Phase 3 Unknown 266 enrolled Peking University Third Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

Patients with diminished ovarian reserve (DOR) who undergo in vitro fertilization and embryo transfer (IVF-ET) are included as the research subjects. The effects of Traditional Chinese Medicine (TCM) for kidney tonifying and blood circulation regulating of different intervention courses on ovarian hyporesponsiveness, IVF-ET outcome and clinical compliance in DOR patients are studied by a non-inferiority randomized controlled trial. The purpose is to identify the breakthrough point and treatment timing of TCM treatment, explore the best treatment course of TCM, and optimize the TCM therapeutic regimen.

Timeline

Start
2022-11-10
Primary completion
2024-12-30
Completion
2024-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject modified Er Xian decoction for promoting fertilization and Si-Wu-Tang Unknown 400 ml —
Subject modified two solstices pill and Si-Wu-Tang Unknown 400 ml —